Seroogy C M, Fathman C G
Department of Medicine, Stanford University School of Medicine, CA 94305-5111, USA.
Immunol Res. 1998 Aug;18(1):15-26. doi: 10.1007/BF02786510.
New insights into the underlying mechanisms for the development of autoimmune diseases in humans and various animal models continue to increase with our understanding of factors that drive polarization of T helper (Th) responses and tolerance. This information has led to the development of new treatment strategies, including oral tolerance clinical trails and the use of altered peptide ligands in animal models. These approaches have shown some promise and provided additional insight into the disease processes. The use of gene therapy in many disease states continues to increase. We are starting to see the application of gene therapy in chronic diseases in humans. Gene therapy has been used in several animal models of autoimmune disease with promising preliminary results. In this article, an overview will be provided for the use of gene therapy in autoimmune disease.
随着我们对驱动辅助性T细胞(Th)反应极化和耐受性的因素的理解不断加深,对于人类和各种动物模型中自身免疫性疾病发病的潜在机制也有了新的认识。这些信息推动了新治疗策略的发展,包括口服耐受临床试验以及在动物模型中使用改变的肽配体。这些方法已显示出一些前景,并为疾病过程提供了更多见解。基因疗法在许多疾病状态下的应用不断增加。我们开始看到基因疗法在人类慢性疾病中的应用。基因疗法已在几种自身免疫性疾病的动物模型中使用,取得了有前景的初步结果。本文将概述基因疗法在自身免疫性疾病中的应用。